Almonertinib (HS-10296) is an orally available, irreversible, third-generation EGFR tyrosine kinase inhibitor with high selectivity for EGFR-sensitizing and T790M resistance mutations.
Molecular Weight:
525.64
Purity:
>99%
CAS Number:
[1899921-05-1]
Target:
EGFR/HER2
* VAT and and shipping costs not included. Errors and price changes excepted